8EZ4

Plasmodium falciparum M17 in complex with inhibitor 9aa

Summary for 8EZ4

• Entry DOI: 10.2210/pdb8ez4/pdb
• Descriptor: M17 leucyl aminopeptidase, N-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)ethyl]-N~2~-phenylglycinamide, SULFATE ION, ... (9 entities in total)
• Functional Keywords: malaria, metalloaminopeptidase, inhibitor complex, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
• Biological source: Plasmodium falciparum (malaria parasite P. falciparum)
• Total number of polymer chains: 12
• Total formula weight: 719394.51

Authors

Calic, P.P.S.,McGowan, S.,Webb, C.T. (deposition date: 2022-10-31, release date: 2023-01-18, Last modification date: 2023-10-25)

• Primary citation: Calic, P.P.S.,Vinh, N.B.,Webb, C.T.,Malcolm, T.R.,Ngo, A.,Lowes, K.,Drinkwater, N.,McGowan, S.,Scammells, P.J.; Structure-based development of potent Plasmodium falciparum M1 and M17 aminopeptidase selective and dual inhibitors via S1'-region optimisation.; Eur.J.Med.Chem., 248:115051-115051, 2022; PubMed: 36634455; DOI: 10.1016/j.ejmech.2022.115051

Experimental method

X-RAY DIFFRACTION (1.89 Å)